As thyroid and lung cancers are often generated by fusion proteins involving RET, Paratala et al. [54] (2018) functionally characterized two RET fusions, named NCOA4-RET and RASGEF1A-RET, which showed oncogenic activity due to the activation of RET kinase, MAPK and PI3K pathways. Here, RET is linked to lung carcinoma.